Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

The Canadian Bioceutical CBICF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannab


GREY:CBICF - Post by User

The Canadian Bioceutical > Confused.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(35)
•••
Comment by LongDollarson Oct 20, 2018 11:47am
127 Views
Post# 28840673

RE:RE:RE:RE:RE:RE:Confused.

RE:RE:RE:RE:RE:RE:Confused.
maybe before you tell someone to use a calculator you should understand the deal yourself - you're %100 wrong. The $1.28 valuation was based on the closing share price of IAN on October 18th of $7.64. They got this valuation of 1.28 by multiplying $7.64x0.1673=$1.278. When the deal is finalized in January (9th I think) you will get that same ratio 0.1673 based on the current share price of IAN. So, if IAN is $10 come the time of the acquisition you will be compensated $1.673 of each MPX you hold. IT IS NOT A RATIO BASED ON QUANTITY OF SHARES IT IS BASED ON THE SHARE PRICE!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities